A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

By Deena Beasley (Reuters) -Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

Rs 14,000 a month—for weight loss.But, but, but… India’s obesity problem is no small fry, and Big Pharma is racing to cash in ...

ABC News chief medical correspondent Dr. Tara Narula explains the findings of a new study on GLP-1 drugs commonly used for weight loss. Dr. Alexandra Sowa, an obesity medicine specialist and autho ...

The challenge of the obesity epidemic is widespread and one that even pediatricians face constantly,” a Connecticut doctor ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...